![20th Anniversary - Logos [RGB]_Growth](/media/131950/20th-anniversary-logos-rgb-_growth.png)
How we helped our client to understand the opportunities across Asia and other emerging markets using interactive outputs
Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low / sub-optimal.
Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low and sub optimimal. Research was required to understand the diabetic patient journey in order to assess the opportunities to expand HCP knowledge on the importance of lipid lowering for type 2 diabetes patients. The client also wanted to explore the drivers and barriers which would influence uptake.
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Novel cancer therapies are offering patients new treatments and better outcomes worldwide. And recent changes in healthcare policies across APAC, such as China’s fast tracking approval of therapies for severe and rare diseases, have reignited interest in the APAC region as a strong market for oncology.
Lunar New Year 2018
Friday 16th February 2018
The Emerging Markets team at Research Partnership would like to wish you a happy and prosperous Lunar New Year. Celebrated in countries across Asia, the Lunar New Year, also known as the Spring Festival, is the longest and most important event in the calendar for many Asian cultures. In China, they celebrate the Chinese New Year, while in South Korea, they celebrate ‘Seollal’ and in Vietnam, they call the traditional holiday ‘Tet’. Despite the difference in names, all of these cultures and more celebrate the beginning of the lunisolar calendar with traditional foods, festivals and fireworks. 2018 celebrates the Year of the Dog, an animal which symbolises luck and promises to deliver a year of innovation and positive change.
Innovation, sustainability and prosperity: Japan’s healthcare vision for the future
By Callum McCulloch and Marc Yates
In 2015, the Japanese government appointed an advisory panel of young experts to lay out its vision of healthcare in the country for 2035. This vision is a healthcare system that delivers unrivalled health outcomes, provides secure and responsive care for all in society, is sustainable, and contributes to prosperity in the nation and around the world.
Yet, how achievable is this ideal, and how does the government plan to realize its vision? What is clear is that it will require a paradigm shift – a move from quantity to quality of care and from inputs to value, on care rather than cure, on autonomy over regulation, on national integration rather than fragmentation.
Ageing Asia: What does the future hold?
Published in eyeforpharma September 2017 by Marc Yates
Over the last 30 years, Asia’s economic growth has resulted in improved education and healthcare across a broad base of the population, contributing to declining fertility and increasing life expectancy. However, in turn, such changing demographic features are set to have profound repercussions on the continent’s socio-economic and healthcare set-up in the coming decades.